Why We Need Support for Endogenous Glutathione

As the body ages it experiences the time-related deterioration of physiological functions. This includes the ability to produce Glutathione, which starts as a gradual decline and compounds over time. This declining insufficiency is further compounded by disease, illness, exposure to environmental toxins and stress – all of which further depletes Glutathione.

The question is – how can levels of Glutathione be raised effectively to combat this eventual depletion? Glutathione is endogenous. Endogenous means it is produced within the body. Oral supplementation of Glutathione (GSH) is inadequate as intestinal enzymes degrade Glutathione as it passes through the digestive tract.

There are other methods, such as intravenous, that can be cost prohibitive to the average patient. Furthermore, the Glutathione molecule itself is too large to pass through the cell wall. To date, the most common and effective means of Glutathione enhancement has been providing the body with known Glutathione precursors.

Historically (since the early 1960s) N-acetylcysteine (NAC), a cysteine precursor, has been the most common solution for Glutathione supplementation. However, there are some issues with NAC supplementation. NAC is easily oxidized and therefore requires larger doses to be effective. As well, it is metabolized rapidly, resulting in a shorter half-life that requires many doses per day.

After nearly a quarter century of research (starting in the mid-1980s) a much more effective means was found to deliver the cysteine precursor to the cells. Through a patented bonding of D-ribose and L-cysteine, this technology allows for cysteine to be more easily absorbed through the digestive system, to then be absorbed into the bloodstream to deliver intact Cysteine and Ribose directly to the cells.

This not only supports Glutathione production through direct supplementation of Cysteine, it provides Ribose as an integral component of Adenosine triphosphate (ATP) – the cells’ natural fuel and source of energy. The patented D-ribose-L-cysteine (DRLC) molecule has already been the subject of over 50 peer reviewed and published studies spanning several decades.